August 28th 2023
With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.
July 31st 2023
The vaccine has been approved since late 2019 for adults age 18 and older.
July 26th 2023
The phase 1/2 trial evaluating EBT-101 dosed its first patient in September 2022.
The update refreshes the organization's 2022 guidance on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, focusing on people in prisons and other closed settings.
April 7th 2023
When taken within 3 days, doxycycline given post-exposure (doxy-PEP) decreased the incidence rates of syphilis, gonorrhea, and chlamydia significantly.
Addressing Weight Gain That Follows Life-Saving Antiretroviral Therapy
Clinicians must identify when additional pounds cross the line of diminishing return.
Missing Early Intervention Leads to Costly Hospital Stays for Patients With HIV
People living with HIV who don’t receive early intervention and primary care end up with a disproportionate share of health care costs, according to a new study that examined barriers to care and costs at a Dublin hospital.
Most People Who Inject Drugs Miss Opportunities for HIV, HCV Testing
PWID are unlikely to receive testing for HIV and hepatitis C, according to a new study that found that 8.5% were tested for HIV and 7.7% were tested for HCV within 1 year of a clinical encounter consistent with injection drug use.
The Impact of ART's High Cost
The rising price of antiretroviral therapy for people living with HIV in the United States is a barrier to adherence. It also blunts efforts to achieve higher rates of viral suppression.
Is 1 Dose Enough for HPV Vaccination?
A new retrospective study provides more evidence that a single HPV vaccine dose may be effective in preventing cervical cancer.
Evaluating HIV Testing Rates on National Black HIV/AIDS Awareness Day
February 7th is commemorated each year to highlight the impact that HIV and AIDS has on the black or African American population in the United States.
Next Steps for HCV Vaccine Development
Andrea L. Cox, MD, PhD, comments on the future of HCV vaccine development efforts in light of the 2019 trial which did not prevent chronic infection.
HIV Vaccine Trial Halted After No Efficacy Observed
NIAID and partner organizations have discontinued HIV vaccination in a South Africa based experimental trial.
Lessons From An HCV Vaccine Trial
Andrea L. Cox, MD, PhD, discusses the implications of discovering that an experimental vaccine was not effective at preventing chronic hepatitis C virus.
Mortality Remains High Among Children Exposed to HIV in Utero in Zimbabwe
A new study provides evidence that more needs to be done to meet the needs of children in rural Zimbabwe who are exposed to HIV.
Frailty is a Predictor for Mortality in Adults With and Without HIV
Regardless of HIV status, frailty was a strong predictor for mortality and comorbidity for middle-aged adults.
FDA Launches Interactive Database on Antiretrovirals for PEPFAR Countries
Through the platform providers, consumers, and procurers will have access to full prescribing inserts and FDA-reviewed product labeling which will provide additional important information to patients and providers.
Finding Resources For Antiretroviral Stewardship
Daniel Chastain, PharmD, BCIDP, discusses how antiretroviral stewardship might practically be implemented in the context that antimicrobial stewardship as a whole is often underdeveloped.
Confidential Community Care For HIV
Max Brito, MD, MPH, explains the value of bringing safe, confidential, and non-stigmatizing HIV treatment to the community at IDWeek2019.
Passive HIV Testing Programs Effective at Reaching High-Risk Residents, Study Suggests
Standalone HIV testing centers in San Diego County, California, have been largely effective at reaching people at high risk of infection, according to a new study that also identified areas where targeted testing efforts may be beneficial.
Study Provides Support for Early ART in HIV-Infected Infants
Babies born with HIV benefit from beginning ART with days—not weeks—of birth.
Study Uncovers How Mycoplasma genitalium Responds to Nutrient Deprivation
A study has revealed the ways Mycoplasma genitalium competes with host organism cells for essential metal nutrients.
Hepatitis C and the Opioid Epidemic
Andrea L. Cox, MD, PhD, compares the rates of hepatitis C and hepatitis B diagnoses since the start of the opioid epidemic.
HIV Transmissions in the UK Continue to Decline
Public Health England reported the promising news that new HIV transmission in the UK continued to decline in 2018.
Trial of Antibiotics Useful in Predicting TB in People with HIV, Study Finds
Using a trial of antibiotics may be useful for predicting tuberculosis in ambulatory patients with HIV, particularly in settings with limited access to resources, a new study suggests.
Why Do People With HIV Lose Smallpox Immunity Despite Vaccination?
Although antiretroviral therapy restores a patient with HIV’s immune system, lingering damage from HIV can render past vaccinations obsolete, a new study finds.
PrEP Users With Commercial Insurance Persist on Regimen Longer Than Medicaid-Insured Individuals
A new study conducted by CDC investigators found that commercially insured patients persisted on PrEP for median time of 13.7 months, compared to 6.8 months among Medicaid patients.
Neural Tube Defect Prevalence Similar Between Infants Exposed to HIV and General Population
The prevalence of NTDs in pregnancies among women with diagnosed HIV infection was 7.0 per 10,000 live births, which was similar to that among the general population.
California's Plan to Improve PrEP Uptake A Model for Other States?: Public Health Watch
New legislation, cost assistance program will likely reduce transmission.
CDC Offers STD Recommendations as Care Shifts to Primary Care Setting
Over the past decade and a half, more Americans have begun to receive STD-related diagnoses and care in a primary care setting. New recommendations from the CDC aim to help ensure quality care amid the shift.
Are Pregnant Women Getting the Right HIV Antiretrovirals?
Roughly half of all American expectant mothers living with HIV are receiving treatments that don’t meet federal guidelines. A new study examines prescribing choices for this population.
Medical Care Coordination Program Can Increase Life Expectancy for People with HIV
Viral suppression at 2 years nearly doubled for people with HIV in a medical care coordination program implemented by the Los Angeles County Division of HIV and STD Programs, a new study found.
Top HIV News of 2019
Contagion® counts down the top HIV news stories of 2019, including FDA approvals, breakthrough discoveries, recommendations from the frontlines, and a big-picture look at just how close we are to ending the epidemic.
Clinics Encourage PrEP Use in Pregnant and Postpartum African Women
A new study out of Africa demonstrates that maternal-child clinics may act as a one-stop shop for both pregnancy and postpartum concerns and HIV protection.
High Costs, Low Health Benefits Predicted for Extending HPV Vaccine
Vaccinating adults ages 27-45 years against human papillomavirus (HPV) was projected to have low public health benefits and high costs, according to a new report.
2 Clarke Drive Cranbury, NJ 08512